Skip links

PharmaFacts for Case Managers - August 2026

Brought to you by the publishers of CareManagement

Read a summary of the essential prescribing information for new FDA-approved drugs in the August issue of PharmaFacts.New drugs include:

  • Lytenava Intravitreal Injection for neovascular age-related macular degeneration
  • Simtriyo Extended-Release Capsules for attention-deficit hyperactivity disorders
  • Tylenol With Naproxen Tablets for pain relief
  • Jideytro Tablets for non–small cell lung cancer
  • Lipfendra Tablets for high cholesterol
  • Revtorpyk Lyophilized Powder for Injection for locally advanced or metastatic breast cancer
  • Sarclisa Escena Injection for multiple myeloma
  • Trutakna Injection for immunoglobulin A nephropathy
  • Tregzi for prophylaxis of graft-versus-host disease
  • Gwyn Lo Transdermal System for birth control

Join ACCM Today

Become a member today to take advantage of the 3 FREE CEs in every issue plus the opportunity to earn the Ethics requirement credits!

Join Now

New and Improved Format

This is a new and improved format for reading CareManagement!

Classic View

Prefer the classic view? You can download and print a PDF of the current issue by clicking the PDF icon located in the bottom of the digital journal (see below).

Supplements with FREE CEUs

Special CareManagement Supplements – Available to All Case Managers.

Read Now
Previous PharmaFacts for Case Managers July 2026

Trusted by certified case managers and certified disability management specialists nationwide.

Stay Current.Stay Certified.Join ACCM.

If you are a CCM or CDMS, and you want to stay on the forefront of your practice, plus fulfill your CE requirements on your time and in your space, then ACCM is for you. Join your colleagues today.

Become a Member
Subscribe to our Newsletter